Peyronie's disease: The epidemiology, aetiology and clinical evaluation of deformity

BJU International

Volumn 95, Issue 6, 2005, Pages 729-732

  Smith, Christopher J ^a   McMahon, Chelsea ^a   Shabsigh, Ridwan ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Aetiology; Clinical evaluation; Epidemiology; Peyronie's disease

Indexed keywords

BLADDER CANCER; BLADDER DYSFUNCTION; CLINICAL FEATURE; CONFERENCE PAPER; DIABETES MELLITUS; EVALUATION; EVIDENCE BASED MEDICINE; HUMAN; MALE; PATHOPHYSIOLOGY; PEYRONIE DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE DISEASE;

FREE RADICALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PENILE INDURATION; PENIS; PHYSICAL EXAMINATION; PROGNOSIS;

EID: 17444413707     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05391.x     Document Type: Conference Paper

References (20)

1. Sommer F, Schwarzer U, Wassmer G et al. Epidemiology of Peyronie's disease. Int J Impot Res 2002; 14: 379-83
2. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie's disease: results of a large survey. BJU Int 2001; 88: 727-30
3. Usta MF, Bivalacqua TJ, Jabren GW et al. Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie's disease. J Urol 2004; 171: 775-9
4. El-Sakka AI, Hassan MU, Nunes L, Bhatnagar RS, Yen TS, Lue TF. Histological and ultrastructural alterations in an animal model of Peyronie's disease. Br J Urol 1998; 81: 445-52
5. Mulhall JP, Anderson MS, Lubrano T, Shankey TV. Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses. Int J Impot Res 2002; 14: 397-405
6. Mulhall JP. Expanding the paradigm for plaque development in Peyronie's disease. Int J Impot Res 2003; 15 (Suppl. 5): S93-102
7. Devine CJ Jr, Somers KD, Jordan SG, Schlossberg SM. Proposal: trauma as the cause of the Peyronie's lesion J Urol 1997; 157: 285-90
8. Akkus E, Carrier S, Baba K et al. Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, ageing and impotence. Br J Urol 1997; 79: 47-53
9. Schiavino D, Sasso F, Nucera E et al. Immunologic findings in Peyronie's disease: a controlled study. Urology 1997; 50: 764-8
10. El-Sakka AI, Hassoba HM, Pillarisetty RJ, Dahiya R, Lue TF. Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. J Urol 1997; 158: 1391-4
11. Mulhall JP, Thom J, Lubrano T, Shankey TV. Basic fibroblast growth factor expression in Peyronie's disease. J Urol 2001; 165: 419-23
12. Mulhall JP, Branch J, Lubrano T, Shankey TV. Perturbation of cell cycle regulators in Peyronie's disease. Int J Impot Res 2001; 13 (Suppl. 5): S21-28
13. Martin DJ, et al. Immunoblot analysis of p53 and cyclin D in Peyronie's disease. Int J Impot Res 2002; 14 (Suppl. ): S10
14. Sikka SC, Helstrom WJ. Role of oxidative stress and antioxidants in Peyronie's disease. Int J Impot Res 2002; 14: 353-60
15. Bivalacqua TJ, Champion HC, Leungwattanakij S et al. Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat. J Androl 2001; 22: 497-506
16. Gholami SS, Gonzalez-Cadavid NF, Lin CS, Rajfer J, Lue TF. Peyronie's disease: a review. J Urol 2003; 169: 1234-41
17. Shabsigh R, Fleming M, Pereman M, Anastasiadis A. Peyronie's Disease Index (PDI); a standardized patient questionnaire. Int J Impot Res 2003; 14 (Suppl. 3): 568
18. Levine LA, Greenfield JM. Establishing a standardized evaluation of the man with Peyronie's disease. Int J Impot Res 2003; 15 (Suppl. 5): S103-12
19. Wilkins CJ, Sriprasad S, Sidhu PS. Colour Doppler ultrasound of the penis. Clin Radiol 2003; 58: 514-23
20. Hauck EW, Hackstein N, Vosshenrich R et al. Diagnostic value of magnetic resonance imaging in Peyronie's disease: a comparison both with palpation and ultrasound in the evaluation of plaque formation. Eur Urol 2003; 43: 293-300